{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:03:43Z","timestamp":1793642623267,"version":"4.5.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.clinthera.2009.08.002","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T04:47:47Z","timestamp":1254804467000},"page":"1844-1855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit\/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials"],"prefix":"10.1016","volume":"31","author":[{"given":"Robert L.","family":"Findling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon B.","family":"Wigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar G.","family":"Bukstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.","family":"Boellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard B.","family":"Abikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Turnbow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Civil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.08.002_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ambp.2006.08.002","article-title":"The economic impact of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"7","author":"Pelham","year":"2007","journal-title":"Ambul Pediatr."},{"key":"10.1016\/j.clinthera.2009.08.002_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00004583-199007000-00007","article-title":"The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study","volume":"29","author":"Barkley","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.biopsych.2004.10.020","article-title":"Attention-deficit\/hyperactivity disorder: A selective overview","volume":"57","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1542\/peds.2004-1959","article-title":"Attention-deficit\/hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications","volume":"115","author":"Wolraich","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2009.08.002_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/001440297103800304","article-title":"The hyperactive child in elementary school: A 5 year, controlled, followup","volume":"38","author":"Minde","year":"1971","journal-title":"Except Child"},{"key":"10.1016\/j.clinthera.2009.08.002_bib7","first-page":"66","article-title":"The diagnosis and management of attention-deficit\/hyperactivity disorder in pediatric patients","volume":"3","author":"Adesman","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jpepsy\/jsm005","article-title":"Attention-deficit\/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology","volume":"32","author":"Spencer","year":"2007","journal-title":"J Pediatr Psychol"},{"issue":"Suppl 7","key":"10.1016\/j.clinthera.2009.08.002_bib9","first-page":"4","article-title":"Attention-deficit\/hyperactivity disorder: A life-span perspective","volume":"59","author":"Biederman","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archpsyc.1996.01830050073012","article-title":"A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders","volume":"53","author":"Biederman","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.148.5.564","article-title":"Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders","volume":"148","author":"Biederman","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1017592030434","article-title":"Families of children with attention-deficit\/hyperactivity disorder: Review and recommenda tions for future research","volume":"4","author":"Johnston","year":"2001","journal-title":"Clin Child Fam Psychol Rev"},{"key":"10.1016\/j.clinthera.2009.08.002_bib13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/00004583-200312000-00008","article-title":"Attention-deficit\/hyperactivity disorder: Increased costs for patients and their families","volume":"42","author":"Swensen","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","article-title":"The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder","volume":"45","author":"Pliszka","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","article-title":"Clinical practice guideline: Treatment of the school-aged child with attention-deficit\/hyperactivity disorder","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2009.08.002_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/000992289903800402","article-title":"National trends in the prevalence of attention-deficit\/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990\u20131995","volume":"38","author":"Robison","year":"1999","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.clinthera.2009.08.002_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","article-title":"Methylphenidate and its isomers: Their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system","volume":"20","author":"Heal","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2009.08.002_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.chi.0000157548.48960.95","article-title":"A dose-ranging study of a methylphenidate transdermal system in children with ADHD","volume":"44","author":"Pelham","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1037\/1064-1297.13.2.111","article-title":"Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD","volume":"13","author":"Pelham","year":"2005","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.08.002_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1087054705284089","article-title":"A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD","volume":"9","author":"McGough","year":"2006","journal-title":"J Atten Disord."},{"key":"10.1016\/j.clinthera.2009.08.002_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4088\/JCP.v69n0120","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit\/hyperactivity disorder [published correction appears in J Clin Psychiatry. 2008;69:329]","volume":"69","author":"Findling","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/CHI.0b013e31816bffdf","article-title":"Varying the wear time of the methylphenidate transdermal system in children with attention-deficit\/hyperactivity disorder","volume":"47","author":"Wilens","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib24","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","year":"2000"},{"key":"10.1016\/j.clinthera.2009.08.002_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","article-title":"The Children's Sleep Habits Questionnaire (CSHQ): Psychometric properties of a survey instrument for school-aged children","volume":"23","author":"Owens","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.clinthera.2009.08.002_bib29","series-title":"ADHD Rating Scale\u2014IV: Checklists, Norms and Clinical Interpretation","author":"DuPaul","year":"1998"},{"key":"10.1016\/j.clinthera.2009.08.002_bib30","series-title":"Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised. DHEW Pub. No. ADM 76-338","first-page":"218","article-title":"Clinical global impressions","year":"1976"},{"key":"10.1016\/j.clinthera.2009.08.002_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/01.CHI.0000046814.95464.7D","article-title":"ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study","volume":"42","author":"Wilens","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.chi.0000157550.94702.a2","article-title":"Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD","volume":"44","author":"McGough","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.chi.0000222788.34229.68","article-title":"Effects of long-term atom-oxetine treatment for young children with attention-deficit\/hyperactivity disorder","volume":"45","author":"Kratochvil","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib34","series-title":"FDA directs ADHD drug manufacturers to notify patients about cardiovascular adverse events and psychiatric adverse events [press release]","year":"2007"},{"key":"10.1016\/j.clinthera.2009.08.002_bib35","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/chi.0b013e31806ad1d7","article-title":"Long-term effects of methylphenidate trans-dermal delivery system treatment of ADHD on growth","volume":"46","author":"Faraone","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.08.002_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00787-005-0486-3","article-title":"12-Month efficacy and safety of OROS MPH in children and adolescents with attention-deficit\/hyperactivity disorder switched from MPH","volume":"14","author":"Hoare","year":"2005","journal-title":"Eur Child Adolesc Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:13Z","timestamp":1758962893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809002665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0149291809002665"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.08.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit\/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}